Guggenheim Reiterates Buy Rating on Neurogene (NGNE)
Guggenheim analyst Debjit Chattopadhyay reiterated a Buy rating and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
